Browsing: Prostate

A large case-control study indicates MRI-based T-staging can replace digital rectal exam-based staging in contemporary risk models without sacrificing prediction…

A large pooled analysis confirms longer non-steroidal anti-androgen (e.g. bicalutamide) use in conjunction with LHRH agonists (e.g. Lupron) beyond the…

A post hoc analysis of the phase III PACE-B trial examines predictors of late grade 2+ GU events following ultra-hypofractionationated…

Building on the landmark FLAME trial, the new ESTRO consensus recommendations provide a practical roadmap for implementing focal boosting in…

Machine learning was used to develop a simple prostate cancer-specific cardiovascular risk score using information already available in oncology clinic…

Top Line: What are the long term outcomes of SBRT for oligometastatic prostate cancer?The Study: Metastasis directed therapy is increasingly…

ArteraAI is a multimodal AI platform that integrates digital pathology and clinical factors. It’s commonly used to risk stratify patients…

Here is the first MRI-based 3D atlas of prostate bed recurrence based on 131 patients harboring 140 local failures after…

Top Line: Is single fraction prostate SBRT safe and effective?The Study: Five fraction SBRT is now a well established standard…

Several studies have investigated the use of SBRT boost similar to brachytherapy boost paired with pelvic radiation for intermediate risk…